共 50 条
- [32] Correction to: Intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in Japan: 24‑month outcomes [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2023, 261 : 283 - 287
- [35] Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema [J]. Scientific Reports, 13
- [36] The clinical utility of aflibercept for diabetic macular edema [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2015, 8 : 473 - 482